These authors put forward their view that the information obtained from experimental human malaria infections justifies the minimal potential risks in well-designed trials and will be essential to the development of an effective malaria vaccine.
- Robert W. Sauerwein
- Meta Roestenberg
- Vasee S. Moorthy